Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP542278.RASql86qcfIeCiRb3KvP64wvm1MXlVF0rK1-bKW45zKjk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP542278.RASql86qcfIeCiRb3KvP64wvm1MXlVF0rK1-bKW45zKjk130_assertion type Assertion NP542278.RASql86qcfIeCiRb3KvP64wvm1MXlVF0rK1-bKW45zKjk130_head.
- NP542278.RASql86qcfIeCiRb3KvP64wvm1MXlVF0rK1-bKW45zKjk130_assertion description "[The expression of Ep-CAM was significantly related to a favorable outcome (p = 0.0185), whereas TROP2 tended to be expressed in cases with an unfavorable outcome (p = 0.0564), and was significantly associated with an unfavorable outcome in nonlepidic-type adenocarcinomas (p = 0.0125).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542278.RASql86qcfIeCiRb3KvP64wvm1MXlVF0rK1-bKW45zKjk130_provenance.
- NP542278.RASql86qcfIeCiRb3KvP64wvm1MXlVF0rK1-bKW45zKjk130_assertion evidence source_evidence_literature NP542278.RASql86qcfIeCiRb3KvP64wvm1MXlVF0rK1-bKW45zKjk130_provenance.
- NP542278.RASql86qcfIeCiRb3KvP64wvm1MXlVF0rK1-bKW45zKjk130_assertion SIO_000772 20473768 NP542278.RASql86qcfIeCiRb3KvP64wvm1MXlVF0rK1-bKW45zKjk130_provenance.
- NP542278.RASql86qcfIeCiRb3KvP64wvm1MXlVF0rK1-bKW45zKjk130_assertion wasDerivedFrom befree-20150227 NP542278.RASql86qcfIeCiRb3KvP64wvm1MXlVF0rK1-bKW45zKjk130_provenance.
- NP542278.RASql86qcfIeCiRb3KvP64wvm1MXlVF0rK1-bKW45zKjk130_assertion wasGeneratedBy ECO_0000203 NP542278.RASql86qcfIeCiRb3KvP64wvm1MXlVF0rK1-bKW45zKjk130_provenance.